These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7134064)

  • 1. Cytophotometric characterization of the WHO grades of transitional cell neoplasms.
    Bjelkenkrantz K; Herder A; Gröntoft O; Stål O
    Pathol Res Pract; 1982 Jul; 174(1-2):68-77. PubMed ID: 7134064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological subgrouping of WHO II urothelial neoplasms by cytophotometric measurements of nuclear atypia.
    Herder A; Bjelkenkrantz K; Gröntoft O
    Acta Pathol Microbiol Immunol Scand A; 1982 Nov; 90(6):405-8. PubMed ID: 7164815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urothelial neoplasia of the urinary bladder--comparison of interobserver variability for WHO Classification 1972 with WHO/ISUP Consensus Classification 1998.
    Mamoon N; Iqbal MA; Jamal S; Luqman M
    J Ayub Med Coll Abbottabad; 2006; 18(2):4-8. PubMed ID: 16977804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feulgen-DNA-values in transitional cell carcinoma of the human urinary bladder.
    Fossä SD
    Beitr Pathol; 1975 May; 155(1):44-55. PubMed ID: 1156320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of cytometric parameters the planning of therapy of urothelial carcinoma].
    Taubert G; Rassler J; Nenning H; Rose S
    Verh Dtsch Ges Pathol; 1993; 77():216-21. PubMed ID: 7511284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
    Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
    Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
    Tamas EF; Epstein JI
    Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistence of papillary and nodular carcinomas in the urinary bladder.
    Kakizoe T; Matsumoto K; Tobisu K; Takai K; Teshima S; Kishi K
    Jpn J Clin Oncol; 1987 Jun; 17(2):179-86. PubMed ID: 3613141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent malakoplakia and papillary urothelial carcinoma of the urinary bladder.
    Darvishian F; Teichberg S; Meyersfield S; Urmacher CD
    Ann Clin Lab Sci; 2001 Apr; 31(2):147-50. PubMed ID: 11337903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up.
    Yin H; Leong AS
    Am J Clin Pathol; 2004 May; 121(5):679-87. PubMed ID: 15151208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The systematic histologic elaboration of urinary bladders with different pathologic findings (urinary bladder carcinoma, tumor-free aging urinary bladders)].
    Theuring U; Theuring F
    Gegenbaurs Morphol Jahrb; 1989; 135(1):203-6. PubMed ID: 2737420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression.
    King ED; Matteson J; Jacobs SC; Kyprianou N
    J Urol; 1996 Jan; 155(1):316-20. PubMed ID: 7490878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome.
    Campbell PA; Conrad RJ; Campbell CM; Nicol DL; MacTaggart P
    BJU Int; 2004 Jun; 93(9):1228-31. PubMed ID: 15180612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of multiple mucosal biopsies in new cases of superficial papillary bladder tumor].
    Kanamaru H; Shirahase T; Moroi S; Taniguchi T; Kuo JY; Okuno H; Kihara Y; Arai Y
    Hinyokika Kiyo; 1993 Feb; 39(2):127-30. PubMed ID: 8465685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of the decision tree technique and image cytometry to characterize aggressiveness in World Health Organization (WHO) grade II superficial transitional cell carcinomas of the bladder.
    Decaestecker C; van Velthoven R; Petein M; Janssen T; Salmon I; Pasteels JL; van Ham P; Schulman C; Kiss R
    J Pathol; 1996 Mar; 178(3):274-83. PubMed ID: 8778332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated tissue eosinophilia in the urinary bladder: is it a real relationship?
    Dworák O; Janssen D
    Appl Pathol; 1989; 7(5):294-7. PubMed ID: 2635616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphometry of bladder carcinoma: definition of a new variable.
    Sowter C; Sowter G; Slavin G; Rosen D
    Anal Cell Pathol; 1990 Jul; 2(4):205-13. PubMed ID: 2275868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of AgNOR analysis of urothelial carcinomas].
    Helpap B; Loesevitz L
    Verh Dtsch Ges Pathol; 1993; 77():222-5. PubMed ID: 7511285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis, staging, and classification of bladder tumors.
    Cummings KB
    Semin Urol; 1983 Feb; 1(1):7-14. PubMed ID: 6679097
    [No Abstract]   [Full Text] [Related]  

  • 20. The cytology of transitional cell carcinoma of the urinary bladder.
    Kern WH
    Acta Cytol; 1975; 19(5):420-8. PubMed ID: 1058612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.